Schedule 13G ownership disclosure

AnaptysBio Inc

Common Stock · CUSIP: 032724106

Event date: 2024-12-31

Reporting persons may disclose overlapping interests. Their amounts are shown individually and are not added into a filing total.

Filing-level shares
Unavailable
Percent of class
Unavailable
  • Frazier Life Sciences Public Fund, L.P.

    Shares: Unavailable · Class: 2.0%

  • FHMLSP, L.P.

    Shares: 612,503.00 · Class: 2.0%

  • FHMLSP, L.L.C.

    Shares: 612,503.00 · Class: 2.0%

  • Frazier Life Sciences Public Overage Fund, L.P.

    Shares: 77,778.00 · Class: 0.3%

  • FHMLSP Overage, L.P.

    Shares: 77,778.00 · Class: 0.3%

  • FHMLSP Overage, L.L.C.

    Shares: 77,778.00 · Class: 0.3%

  • Frazier Life Sciences X, L.P.

    Shares: 77,014.00 · Class: 0.3%

  • FHMLS X, L.P.

    Shares: 77,014.00 · Class: 0.3%

  • FHMLS X, L.L.C.

    Shares: 77,014.00 · Class: 0.3%

  • Frazier Life Sciences XI, L.P.

    Shares: 165,521.00 · Class: 0.5%

  • FHMLS XI, L.P.

    Shares: 165,521.00 · Class: 0.5%

  • FHMLS XI, L.L.C.

    Shares: 165,521.00 · Class: 0.5%

  • Frazier Healthcare VII, L.P.

    Shares: 498,769.00 · Class: 1.6%

  • Frazier Healthcare VII-A, L.P.

    Shares: 142,134.00 · Class: 0.5%

  • FHM VII, L.P.

    Shares: 640,903.00 · Class: 2.1%

  • FHM VII, L.L.C.

    Shares: 640,903.00 · Class: 2.1%

  • James N. Topper

    Shares: 1,655,295.00 · Class: 5.4%

  • Patrick J. Heron

    Shares: 1,583,593.00 · Class: 5.2%

  • Albert Cha

    Shares: 690,281.00 · Class: 2.3%

  • James Brush

    Shares: 690,281.00 · Class: 2.3%

  • Daniel Estes

    Shares: 165,521.00 · Class: 0.5%

  • Alan Frazier

    Shares: 640,903.00 · Class: 2.1%

  • Nader Naini

    Shares: 640,903.00 · Class: 2.1%

  • Nathan Every

    Shares: 645,526.00 · Class: 2.1%

  • Brian Morfitt

    Shares: 646,272.00 · Class: 2.1%

Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.

Source: SEC EDGAR filing

Filing metadata

Accession number
0001415889-25-003989
Form type
SCHEDULE 13G/A
Filer
ANAPTYSBIO, INC
CIK
CIK 1370053
Filed
Feb 14, 2025
Reporting period
Dec 31, 2024
Description
Schedule 13G beneficial ownership

Explore SEC Filings Hub